Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1021/acschemneuro.0c00422 http://scihub22266oqcxt.onion/10.1021/acschemneuro.0c00422 32709193!ä!32709193       ACS+Chem+Neurosci 2020 ; 11 (15): 2156-2158 Nephropedia Template TP {{tp|p=32709193|t=2020. Lung Injury in COVID-19-An Emerging Hypothesis |pdf=|usr=}}{{32709193}} gab.com Text Lung Injury in COVID-19-An Emerging Hypothesis JO: ACS Chem Neurosci http://www.kidney.de/pget.php?&tw=1&pmid=32709193 #FOAvip Lung injury with COVID-19 may be due to a complex underlying pathophysiology. Cytokine release syndrome appears to be a catalyst of different inflammatory pathways promoting lung parenchymal injury and thromboembolic phenomena ("dual hit" injury). Recently, severe neurological manifestations such as acute disseminated encephalomyelitis, which may be not linked to lung pathology, have been identified in COVID-19, contributing thus further to the versatility of its clinical features. Twit Text FOAVip Lung Injury in COVID-19-An Emerging Hypothesis ????ACS Chem Neurosci http://www.kidney.de/pget.php?&tw=1&pmid=32709193 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32709193 #FOAvip English Wikipedia <ref>{{Cite pmid|32709193}}</ref> Lung Injury in COVID-19-An Emerging Hypothesis #MMPMID32709193 Alharthy A; Faqihi F; Memish ZA; Karakitsos D ACS Chem Neurosci 2020[Aug]; 11 (15): 2156-2158 PMID32709193show ga Lung injury with COVID-19 may be due to a complex underlying pathophysiology. Cytokine release syndrome appears to be a catalyst of different inflammatory pathways promoting lung parenchymal injury and thromboembolic phenomena ("dual hit" injury). Recently, severe neurological manifestations such as acute disseminated encephalomyelitis, which may be not linked to lung pathology, have been identified in COVID-19, contributing thus further to the versatility of its clinical features. |Animals[MESH] |Betacoronavirus/*metabolism[MESH] |COVID-19[MESH] |Coronavirus Infections/complications/*metabolism/physiopathology[MESH] |Cytokines/*metabolism[MESH] |Humans[MESH] |Lung Injury/etiology/*metabolism/physiopathology[MESH] |Pandemics[MESH] |Pneumonia, Viral/complications/*metabolism/physiopathology[MESH]Lung Injury in COVID-19-An Emerging Hypothesis (epmc).pdf DeepDyve Pubget Overpricing